Welcome to our dedicated page for Enova Intl SEC filings (Ticker: ENVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Enova International funds high-velocity online loans or how rising delinquency rates impact margins often requires piecing together hundreds of pages across multiple forms. From securitization footnotes to state-specific lending caps, the disclosures can be daunting. If you’ve ever searched for “Enova International insider trading Form 4 transactions” or “Enova International quarterly earnings report 10-Q filing,” you know the challenge: the data exists, but it’s scattered.
Stock Titan solves that problem. Our AI-powered engine delivers “Enova International SEC filings explained simply,” turning raw documents into clear insights. Need “Enova International Form 4 insider transactions real-time” alerts? We surface them the moment they hit EDGAR and highlight which executive bought or sold. Want an “Enova International annual report 10-K simplified” walkthrough that pinpoints credit loss trends, funding costs, and regulatory risks? One click. Our coverage spans every filing type—10-Q, 8-K, DEF 14A, S-3—plus redlined comparisons and keyword search, so “understanding Enova International SEC documents with AI” becomes part of your daily workflow.
The platform connects filing types to what matters for a consumer-lending fintech. The 10-Q reveals net charge-offs; we transform that into a quarter-over-quarter chart for “Enova International earnings report filing analysis.” The proxy shows “Enova International proxy statement executive compensation,” including pay metrics tied to loan performance. Form 4 feeds flag “Enova International executive stock transactions Form 4,” letting you monitor insider sentiment before headlines move the stock. Even sudden disclosures are covered: “Enova International 8-K material events explained” highlights funding facility amendments or regulator inquiries within minutes. With real-time updates, AI summaries, and expert commentary, you can act on complete information instead of searching for it.
Form 4 highlights for Enova International, Inc. (ENVA): On 06/20/2025, Chief Executive Officer and Director David Fisher exercised 2,000 non-qualified stock options at an exercise price of $23.96 (code “M”) and immediately sold the same 2,000 common shares in the open market at a weighted-average price of $98.4214 (code “S”).
• Gross spread captured: approximately $74.46 per share, or roughly $149,000 in pre-tax proceeds.
• Remaining direct ownership: 348,223 common shares after the transactions, down from 350,223.
• Outstanding options: 170,562 options remain unexercised on the same grant, expiring 02/12/2026. The option set vested in three equal tranches between 2020 and 2022.
The sale was executed under Fisher’s established Rule 10b5-1 trading plan, limiting the informational signal for investors. The option/SAR pair was granted with a limited stock-appreciation right that becomes exercisable only upon a Change in Control scenario; exercising the option automatically terminates the corresponding SAR.
Materiality assessment: The transaction represents less than 1% of Fisher’s total common-stock holdings and does not involve new share issuance or company-level cash flows. Therefore, the filing is viewed as routine insider portfolio management, with negligible direct effect on Enova’s capital structure or near-term financial outlook.
Enova International, Inc. (ENVA) has filed a Form 144 notifying the SEC of a proposed sale of 2,000 common shares through Merrill Lynch on the NYSE, tentatively scheduled for 06/20/2025. The aggregate market value is listed at $196,760, implying an estimated price of about $98.38 per share. With 25,366,770 shares outstanding, the transaction represents less than 0.01 % of total shares.
The filing names David Fisher as the seller. Over the past three months he has already disposed of 9,000 shares (5,000 on 03/25/2025, 2,000 on 04/28/2025 and 2,000 on 05/22/2025) for cumulative gross proceeds of $888,721.90. If the newly noticed sale is executed, total dispositions would rise to 11,000 shares. The shares being sold were originally acquired via stock-option exercises in February 2019.
Form 144 filings merely signal an intent and do not obligate the insider to complete the sale. The document contains no additional financial metrics or strategic commentary.